1/2

Export Ready

MYTERA 500 MG (ABIRATERONE ACETATE TABLETS)

Name: MYTERA 500 MG (ABIRATERONE ACETATE TABLETS)
SKU: 8416380
Price: 46.48 USD
Availability: InStock

Sold by umesh kumar pyarelal gupta · Distributor, Exporter, Importer, Wholesaler · Mumbai, Maharashtra, India

Price

₹ 46.48 /Centimetre

In stock

MRP ~~₹ 202.91~~

Inclusive of all taxes

You Save: ₹ 156.43

Minimum order: 1 Centimetre

Export Snapshot

MOQ

1 Centimetre

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

As per product specification

HS Code

30042099

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for umesh kumar pyarelal gupta.

Compliance & Certifications

Suitable for

Importers · Distributors · Wholesalers

Mumbai Dispatch on request Verified seller

umesh kumar pyarelal gupta

Distributor, Exporter, Importer, Wholesaler · Mumbai, Maharashtra, India

Trigen Enterprises is a reputable pharmaceutical distributor based in Mumbai, operating since 2014. As authorized distributors and stockists for leading pharmaceutical companies such as Reliance Life Science, Mylan, Biocon, and Hetero Trigen Enterprises specializes in the oncology segment, offering high-quality products to healthcare providers. The company also engages in government tenders, including IHNS Ashvini, ensuring the availability of essential medications across sectors

Registered address: Mumbai, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Drugs & Pharmaceuticals.

View profile All products

Established

2014

Employees

1–10

GST

27AJVPG8610J1ZQ

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Oct 2024

Turnover

50000001 - 100000000.

Incorporation Type

On request

Verified Seller

Product details

What are the specifications of this product?

Overview

MYTERA 500 MG (Abiraterone Acetate Tablets) is a potent pharmaceutical formulation specifically designed for the treatment of advanced prostate cancer. Each tablet contains 500 mg of Abiraterone Acetate, a selective inhibitor of the CYP17 enzyme, which is critical in androgen biosynthesis. By inhibiting CYP17, MYTERA effectively reduces androgen production in testes, adrenal glands, and prostate tumor tissue, helping to manage hormone-sensitive and castration-resistant prostate cancer. This medication is intended for prescription use under the supervision of oncologists and healthcare professionals and is commonly employed in combination with prednisone to enhance therapeutic outcomes. MYTERA offers sustained release and optimal bioavailability to ensure consistent plasma concentrations for effective cancer control. Suitable for administration in adult male patients with metastatic castration-resistant prostate cancer, MYTERA 500 MG is an essential part of targeted hormone therapy protocols.

Product Description

Description provided by umesh kumar pyarelal gupta.

Specifications

Tablet Strength	500 mg
Composition	Abiraterone Acetate, Excipients
Pharmacological Class	Androgen biosynthesis inhibitor
Shelf Life	24 months from manufacturing date
Storage Conditions	Store below 25°C, protect from moisture and light
Regulatory Approval	Approved by CDSCO (India) and other relevant authorities
Prescription Status	Prescription Only Medicine (POM)
Tablet Appearance	Round, film-coated, white to off-white tablets

Use cases

Category	Pharmaceuticals > Oncology Medicines > Hormonal Therapy
Primary application	Wholesale, distribution, and international sourcing
Brand	Not specified
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 Centimetre
Lead time	On request
Payment terms	As per negotiated commercial agreement.
Checkout type	enquiry

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing MYTERA 500 MG (ABIRATERONE ACETATE TABLETS). Answers compiled from verified sellers' commercial terms and platform data.

Q: Is MYTERA 500 MG suitable for all stages of prostate cancer?

A: MYTERA 500 MG is specifically approved and recommended for metastatic castration-resistant prostate cancer and hormone-sensitive prostate cancer under specific conditions, but may not be suitable for early-stage prostate cancer.

Q: Can MYTERA 500 MG be used without prednisone?

A: MYTERA is generally prescribed in combination with low-dose prednisone to mitigate side effects; use without prednisone should only be under strict medical supervision.

Q: What are the storage requirements for MYTERA 500 MG tablets?

A: Store MYTERA tablets below 25°C in a dry place, protected from moisture and light to maintain efficacy.

Q: Is MYTERA 500 MG available for bulk purchase for hospital use?

A: Yes, MYTERA 500 MG is available for bulk orders suitable for hospital pharmacies and cancer treatment centers.

Q: Does MYTERA 500 MG require special certification for import or sale in India?

A: Yes, MYTERA 500 MG requires CDSCO approval and is a prescription-only medication compliant with Indian pharmaceutical regulations.

Question not answered? Ask sellers directly — typical response within 4 hours.